Management of Positive HSV-1 Test Result

Clinical Assessment and Decision Algorithm

The American College of Physicians and the Infectious Diseases Society of America recommend that for a positive HSV-1 test, management depends entirely on whether the patient has active symptoms: treat symptomatic patients with oral antivirals, but asymptomatic patients with positive serology alone require only counseling—not antiviral therapy 1, 2
For active lesions present (first episode), the Centers for Disease Control and Prevention recommend Valacyclovir 1 g orally twice daily for 7-10 days (preferred regimen) 2, 3
For recurrent episodes, the Centers for Disease Control and Prevention recommend Valacyclovir 500 mg orally twice daily for 5 days 2, 3
Treatment must be initiated during prodrome or within 1 day of lesion onset for maximum benefit 4

The Infectious Diseases Society of America notes that genital HSV-1 has significantly less viral shedding and fewer recurrences compared to HSV-2 1
The Centers for Disease Control and Prevention state that suppressive therapy is NOT routinely recommended for genital HSV-1 because the risk-benefit ratio is unfavorable given infrequent recurrences 1
For severe disease requiring hospitalization, the Centers for Disease Control and Prevention recommend Acyclovir 5-10 mg/kg IV every 8 hours for 5-7 days for disseminated infection, encephalitis, pneumonitis, or hepatitis 3, 5

The American College of Obstetricians and Gynecologists and the Infectious Diseases Society of America recommend that all patients with positive HSV-1 tests require comprehensive education, regardless of symptom status: explain that HSV-1 establishes lifelong latent infection that antivirals control but do not eradicate 1, 4
The Centers for Disease Control and Prevention note that asymptomatic viral shedding occurs and can transmit infection even without visible lesions 3, 4
The American College of Physicians recommends that patients abstain from sexual contact when prodromal symptoms or lesions are present 3, 4
The Infectious Diseases Society of America advises that patients use condoms consistently during all sexual exposures (provides partial but not complete protection) 3, 4

The Infectious Diseases Society of America warns against treating based solely on positive serology without clinical symptoms 2
The Centers for Disease Control and Prevention caution against delaying treatment beyond 72 hours of symptom onset 2
The American College of Physicians advises against using topical acyclovir 2
The Infectious Diseases Society of America notes that suppressive therapy does not prevent all transmission 3
The Centers for Disease Control and Prevention recommend against stopping antiviral therapy prematurely in severe cases based on single negative CSF PCR 5

The Centers for Disease Control and Prevention recommend that after 1 year of continuous suppressive therapy (if prescribed), discontinue to reassess recurrence frequency 3
For severe disease, the Infectious Diseases Society of America recommends repeat CSF examination at 14-21 days to confirm viral clearance 5